These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8427765)

  • 1. Arteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events.
    Brown BG; Zhao XQ; Sacco DE; Albers JJ
    Br Heart J; 1993 Jan; 69(1 Suppl):S48-53. PubMed ID: 8427765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.
    Brown BG; Zhao XQ; Sacco DE; Albers JJ
    Circulation; 1993 Jun; 87(6):1781-91. PubMed ID: 8504494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of endothelial function in mediating the benefits of lipid-lowering therapy.
    Brown BG; Zhao XQ
    Am J Cardiol; 1998 Nov; 82(10B):49T-52T. PubMed ID: 9860375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerosis regression, plaque disruption, and cardiovascular events: a rationale for lipid lowering in coronary artery disease.
    Brown BG; Zhao XQ; Sacco DE; Albers JJ
    Annu Rev Med; 1993; 44():365-76. PubMed ID: 8476257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipid factors and evolution of the atherosclerotic plaque: review of recent trials].
    Scardi S
    G Ital Cardiol; 1996 Dec; 26(12):1481-93. PubMed ID: 9162677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-lowering therapy after coronary revascularization: the interventional cardiologist's perspective.
    Lansky AJ; Popma JJ; Mintz GS; Laird JR; Saucedo JF; Leon MB
    Am J Cardiol; 1998 Apr; 81(7A):55E-62E. PubMed ID: 9551596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression and regression of the atherosclerotic plaque.
    de Feyter PJ; Vos J; Deckers JW
    Eur Heart J; 1995 Aug; 16 Suppl I():26-30. PubMed ID: 8829954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary heart disease prevention and the infarctogenic plaque.
    Lewis B
    Isr J Med Sci; 1996 Jun; 32(6):360-3. PubMed ID: 8682641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pixel or death: experience from clinical trials assessing lipid lowering therapy.
    Barth JD
    Can J Cardiol; 1995 May; 11 Suppl C():9C-14C. PubMed ID: 7750051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of severe atherosclerotic plaque in patients with mild elevation of LDL cholesterol.
    Schaefer S; Hussein H; Gershony GR; Rutledge JC; Kappagoda CT
    J Investig Med; 1997 Dec; 45(9):536-41. PubMed ID: 9444880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relationship between clinical events and the angiographic lesions in coronary atherosclerosis. Hypolipemic treatment and plaque stabilization].
    Castro Beiras A; Vázquez Rodríguez JM; Muñiz J; Calviño R; Vázquez González N; Juane R
    Rev Esp Cardiol; 1995; 48 Suppl 5():23-30. PubMed ID: 7494936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study.
    Cheng JM; Suoniemi M; Kardys I; Vihervaara T; de Boer SP; Akkerhuis KM; Sysi-Aho M; Ekroos K; Garcia-Garcia HM; Oemrawsingh RM; Regar E; Koenig W; Serruys PW; van Geuns RJ; Boersma E; Laaksonen R
    Atherosclerosis; 2015 Dec; 243(2):560-6. PubMed ID: 26523994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial endpoints: angiograms, events, and plaque instability.
    Ballantyne CM
    Am J Cardiol; 1998 Sep; 82(6A):5M-11M. PubMed ID: 9766342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular computed tomographic assessment of the effect of combination lipoprotein therapy on coronary arterial plaque: rationale and design of the AFRICA (Atorvastatin plus Fenofibric acid in the Reduction of Intermediate Coronary Atherosclerosis) study.
    Voros S; Joshi PH; Vazquez G; Roth G; Murrieta L; Rinehart S; Qian Z; Miller J
    J Cardiovasc Comput Tomogr; 2010; 4(3):164-72. PubMed ID: 20413364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms underlying reduction of clinical events in lipid lowering trials.
    Mancini GB
    Can J Cardiol; 1995 May; 11 Suppl C():15C-17C. PubMed ID: 7750043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease: a review.
    Frisinghelli A; Mafrici A
    Clin Drug Investig; 2007; 27(9):591-604. PubMed ID: 17705568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Intensive Versus Moderate Lipid-Lowering Therapy on Fibrous Cap and Atheroma Volume of Coronary Lipid-Rich Plaque Using Serial Optical Coherence Tomography and Intravascular Ultrasound Imaging.
    Hou J; Xing L; Jia H; Vergallo R; Soeda T; Minami Y; Hu S; Yang S; Zhang S; Lee H; Yu B; Jang IK
    Am J Cardiol; 2016 Mar; 117(5):800-6. PubMed ID: 26778524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study.
    Kuroda M; Shinke T; Sakaguchi K; Otake H; Takaya T; Hirota Y; Sugiyama D; Nakagawa M; Hariki H; Inoue T; Osue T; Taniguchi Y; Iwasaki M; Nishio R; Kinutani H; Konishi A; Hiranuma N; Takahashi H; Terashita D; Hirata KI
    JACC Cardiovasc Interv; 2015 May; 8(6):800-811. PubMed ID: 25999102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversibility of atherosclerosis--evolving perspectives from two arterial imaging clinical trials: the cholesterol lowering atherosclerosis regression study and the monitored atherosclerosis regression study.
    Hodis HN
    J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S25-31. PubMed ID: 8907211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new paradigm for plaque stabilization.
    Ambrose JA; Martinez EE
    Circulation; 2002 Apr; 105(16):2000-4. PubMed ID: 11997290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.